Shares of Allurion Technologies Inc (NYSE:ALUR) climbed 2.9% after the company announced a strategic distribution partnership with Canadian medical device firm Minogue Medical Inc., which specializes in bariatric and obesity treatment solutions.
This collaboration taps into Minogue Medical’s four decades of experience in the Canadian healthcare market and its broad network of dietitians, bariatric surgeons, and endoscopic specialists. The partnership aims to broaden Allurion’s reach across Canada by leveraging Minogue’s reputation for introducing advanced medical technologies through thorough vetting and training programs.
By joining forces, Allurion plans to expand access to its weight loss program, particularly when paired with GLP-1 therapies to improve both immediate and sustained outcomes. The company highlights its focus on “metabolically healthy weight loss,” a strategy designed to promote fat loss while preserving muscle and supporting long-term weight maintenance.
“This agreement with Minogue Medical reflects our commitment to find partners globally who believe in our approach to obesity care,” said Dr. Shantanu Gaur, Founder and CEO of Allurion. “We are looking forward to working with Minogue to develop the Canadian market and establish a new standard of care in the treatment of obesity.”
Minogue Medical CEO Danny Minogue added, “We select partners who share our vision for ethical, patient-centered care. Allurion’s commitment to clinical rigor complements our approach, and together, we intend to set a new benchmark in Canadian weight management.”
Allurion Technologies stock price
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.